Inflammation and CV risk: Beyond statins in the treatment of atherosclerosis - PACE-CME

Inflammation and CV risk Beyond statins in the treatment of atherosclerosis

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Anti-inflammatory therapies for CVD risk prevention
Anti-inflammatory therapies for CVD risk prevention
EAS 2024
Anti-inflammatory therapies for CVD risk prevention
- Ulrich Laufs, MD, PhD
Pro/con debate: Are we ready to treat inflammation for ASCVD prevention?
Pro/con debate: Are we ready to treat inflammation for ASCVD prevention?
EAS 2024
Pro/con debate: Are we ready to treat inflammation for ASCVD prevention?
- Ulrich Laufs, MD, PhD
- Paul Ridker, MD
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
ESC Congress 2023
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
- Stephen Nicholls, MD
Lessons from a trial with colchicine in patients undergoing thoracic surgery
Lessons from a trial with colchicine in patients undergoing thoracic surgery
ESC Congress 2023
Lessons from a trial with colchicine in patients undergoing thoracic surgery
- Lukas Hoes, MD
- David Conen, MD